Drug Approval | November 20, 2023
Teva announces approval of a generic version of Forteo in US
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
The company has raised US$4.5 million in funding for its AI operating system
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Subscribe To Our Newsletter & Stay Updated
